Are serum levels of tissue inhibitor of metalloproteinase-1 correlated with liver fibrosis in patients with chronic hepatitis B?
TIMP-1 is a valuable single biomarker for the evaluation of significant fibrosis in CHB patients.
Weight gain rate during inpatient treatment for AN was a significant predictor of short-term clinical outcome after discharge. It is unclear whether weight gain rate exerts a causal effect or is rather a marker for readiness to tolerate weight restoration and engage in the recovery process.